Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3695]

Mutations associated with sensitivity or resistance to immunotherapy in mNSCLC

Mutations associated with sensitivity or resistance to immunotherapy in mNSCLC

Protein mapping pinpoints why metastatic melanoma patients do not respond to immunotherapy

Protein mapping pinpoints why metastatic melanoma patients do not respond to immunotherapy

Precious metal flecks could be catalyst for better cancer therapies

Precious metal flecks could be catalyst for better cancer therapies

More targeted, less toxic: The golden future of cancer treatment

More targeted, less toxic: The golden future of cancer treatment

The potential of antihistamines in causing the death of leukaemic stem cells

The potential of antihistamines in causing the death of leukaemic stem cells

Preclinical study reveals the impact of age on immunotherapy treatment for breast cancer

Preclinical study reveals the impact of age on immunotherapy treatment for breast cancer

Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients

Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients

Trifluridine/tipiracil receives marketing authorisation in Europe for patients with previously treated metastatic gastric cancer

Trifluridine/tipiracil receives marketing authorisation in Europe for patients with previously treated metastatic...

New mathematical model can improve radiation therapy of brain tumours

New mathematical model can improve radiation therapy of brain tumours

FAK protein linked to chemotherapy resistance in ovarian cancer

FAK protein linked to chemotherapy resistance in ovarian cancer

More from ecancer